Literature DB >> 9633759

Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease.

E Hollenbach1, S Ackermann, B T Hyman, G W Rebeck.   

Abstract

C766T, a polymorphism in exon 3 of the gene for the low-density lipoprotein receptor-related protein (LRP), was found to be associated with late-onset Alzheimer's disease (AD). We developed a PCR-restriction enzyme-based assay to analyze this allele in 234 AD patients and 103 controls. We confirmed that the LRP C766T polymorphism was in disequilibrium with AD--the C/C genotype was present in 76% of AD patients and 60% of controls (p < 0.01); however, the LRP polymorphism did not influence age at onset of AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633759     DOI: 10.1212/wnl.50.6.1905

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

Review 2.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

3.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 4.  Low-density lipoprotein receptor family: endocytosis and signal transduction.

Authors:  Y Li; J Cam; G Bu
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

5.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

6.  Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.

Authors:  Yuji Kajiwara; Sonia Franciosi; Nagahide Takahashi; Lisa Krug; James Schmeidler; Kevin Taddei; Vahram Haroutunian; Ulrik Fried; Michelle Ehrlich; Ralph N Martins; Samuel Gandy; Joseph D Buxbaum
Journal:  Mol Neurodegener       Date:  2010-01-14       Impact factor: 14.195

7.  Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics.

Authors:  R Mayeux; J H Lee; S N Romas; D Mayo; V Santana; J Williamson; A Ciappa; H Z Rondon; P Estevez; R Lantigua; M Medrano; M Torres; Y Stern; B Tycko; J A Knowles
Journal:  Am J Hum Genet       Date:  2001-11-19       Impact factor: 11.025

Review 8.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

9.  Increased exonic de novo mutation rate in individuals with schizophrenia.

Authors:  Simon L Girard; Julie Gauthier; Anne Noreau; Lan Xiong; Sirui Zhou; Loubna Jouan; Alexandre Dionne-Laporte; Dan Spiegelman; Edouard Henrion; Ousmane Diallo; Pascale Thibodeau; Isabelle Bachand; Jessie Y J Bao; Amy Hin Yan Tong; Chi-Ho Lin; Bruno Millet; Nematollah Jaafari; Ridha Joober; Patrick A Dion; Si Lok; Marie-Odile Krebs; Guy A Rouleau
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

10.  C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65.

Authors:  Madepalli K Lakshmana; Eunice Chen; Il-Sang Yoon; David E Kang
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.